SPL
Click for more information
9.20% 9.5¢ starpharma holdings limited

The similar results has been reported and published in Nature....

  1. forestgump85
    54 Posts.
    clock Created with Sketch.
    26/07/17
    08:43
    Post #: 26079495
    The similar results has been reported and published in Nature. Roche (Herceptin, HER2-antibody) should be one of secret party, they are too big to name on SPL reports. Btw, the critical utmost achievement for DEP is HER2-DEP, cause now Herceptin is confirmed as supporting chemotherapy, it just blocked the growth signals of cells, and prevent cancer recurrent rather than kill cancel cells.
    So HER2-DEP-toxic cell drugs should be developed to fill the gaps.
    SPL Price at posting: 79.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢ 		Change
0.008(9.20%) 		Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.